Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.59 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | GMNN | O75496 | 3/20 | 0.59 |
| ▸ | POLB | P06746 | 3/20 | 0.59 |
| ▸ | BLM | P54132 | 3/20 | 0.59 |
| ▸ | CETP | P11597 | 3/20 | 0.59 |
| ▸ | UBE2N | P61088 | 3/20 | 0.59 |
| ▸ | TP53 | P04637 | 3/20 | 0.59 |
| ▸ | THPO | P40225 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | MTOR | P42345 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | GLA | P06280 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21549711 | 0.93 | LMNA (0.50) | LMNACYP2D6SPHK1MAPTGMNN | |
| SCHEMBL11590246 | 0.84 | LMNA (0.50) | LMNACYP2D6SPHK1MAPTGMNN | |
| SCHEMBL28446529 | 0.84 | OPRM1 (0.50) | LMNACYP2D6SPHK1MAPTGMNN | |
| SCHEMBL1168786 | 0.84 | CYP2D6 (0.54) | LMNACYP2D6SPHK1MAPTGMNN | |
| SCHEMBL29174054 | 0.82 | OPRM1 (0.48) | LMNACYP2D6SPHK1MAPTGMNN | |
| SCHEMBL29286449 | 0.82 | OPRM1 (0.48) | LMNACYP2D6SPHK1MAPTGMNN | |
| SCHEMBL11252076 | 0.80 | LMNA (0.47) | LMNACYP2D6SPHK1MAPTGMNN | |
| SCHEMBL4954386 | 0.80 | OPRM1 (0.46) | LMNACYP2D6SPHK1MAPTGMNN | |
| SCHEMBL4950681 | 0.80 | OPRM1 (0.46) | LMNACYP2D6SPHK1MAPTGMNN | |
| SCHEMBL4946266 | 0.80 | OPRM1 (0.46) | LMNACYP2D6SPHK1MAPTGMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140073634-A1 | HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE | Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center (US) | 2014-03-13 | — | — | US | disclosed |
| US-8481652-B2 | Thermoplastic polyamides having polyether amines | BASF SE (DE) | 2013-07-09 | — | — | US | disclosed |
| WO-2012007301-A3 | FOAM ENHANCEMENT OF FATTY ACYL GLYCINATE SURFACTANTS | UNILEVER PLC (GB) | 2012-05-10 | — | — | WO | disclosed |
| EP-2257597-B1 | POLYAMIDE NANOCOMPOSITES WITH HYPER- BRANCHED POLYETHERAMINES | BASF SE (DE) | 2011-11-30 | — | — | EP | disclosed |
| EP-2227507-B1 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2011-08-31 | — | — | EP | disclosed |
| US-20110021686-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHERAMINES | BASF SE (DE) | 2011-01-27 | — | — | US | disclosed |
| US-20110021687-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHYLENEIMINES | BASF SE (DE) | 2011-01-27 | — | — | US | disclosed |
| US-20110009566-A1 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2011-01-13 | — | — | US | disclosed |
| EP-2257597-A2 | POLYAMIDE NANOCOMPOSITES WITH HYPER- BRANCHED POLYETHERAMINES | BASF SE (DE) | 2010-12-08 | — | — | EP | disclosed |
| EP-2254949-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHYLENIMINES | BASF SE (DE) | 2010-12-01 | — | — | EP | disclosed |
| EP-2227507-A2 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2010-09-15 | — | — | EP | disclosed |
| WO-2010028975-A2 | THERMALLY CONDUCTIVE POLYAMIDE HAVING INCREASED FLOW CAPABILITY | BASF SE (DE) | 2010-03-18 | — | — | WO | disclosed |
| WO-2009115535-A2 | POLYAMIDE NANOCOMPOSITES WITH HYPER- BRANCHED POLYETHERAMINES | BASF SE (DE) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009115536-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHYLENIMINES | BASF SE (DE) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009077492-A2 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2009-06-25 | — | — | WO | disclosed |
| WO-2009050094-A1 | THERMOPLASTIC POLYESTER MOLDING COMPOUNDS COMPRISING HIGHLY BRANCHED POLYETHER AMINES | BASF SE (DE) | 2009-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140073634-A1 | HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE | HIF1AN, HIF1A, EGLN3 | LMNA 3216/4885CYP2D6 2361/4885SPHK1 1638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.